Trump Announces Major Drug Price Cuts with Pharma Giants

 Trump Announces Major Drug Price Cuts with Pharma Giants

Washington — President Donald J. Trump hosted executives from nine leading pharmaceutical companies at the White House to unveil new agreements slashing U.S. drug prices. The deals implement "Most Favored Nation" pricing, matching U.S. costs for key medications to the lowest rates in other wealthy nations, often up to 10 times cheaper. Flagship drugs will see dramatic reductions for Medicaid patients and cash payers, ending what Trump called unfair "global freeloading" on American consumers. In exchange, companies commit billions in U.S. manufacturing, R&D investments, and donations to national stockpiles. This expands prior pacts, now covering 14 of the 17 largest pharma firms, with tariff threats helping secure compliance. Trump hailed it as the biggest victory for patient affordability in U.S. healthcare history. Foreign nations are reportedly adjusting prices in response. The initiative builds on Trump's ongoing push to lower prescription costs. Analysts note significant savings potential for vulnerable patients. What questions do you have? Please share your opinion below 👇